The Centers for Disease Control and Prevention (CDC) has updated its recommendations regarding COVID-19 vaccinations for ...

NEW YORK (AP) — U.S. health officials on Wednesday recommended that people 50 and older get a shot against bacteria that can ...

Immunocompromised adults or those who are older than 65 should get a second dose of the latest COVID-19 vaccine, the Centers ...

COVID-19 2024–2025 vaccines are recommended for everyone aged 6 months and older, with vaccines targeting the JN.1 and KP.2 strains of SARS-CoV-2.

Leerink Partners analyst David Risinger has maintained their neutral stance on PFE stock, giving a Hold rating on October 21. David Risinger ...

Pfizer's focus should remain on existing cost realignment plans and pipeline investments. Read why my investment thesis ...

which underpins Pfizer and BioNTech's COVID-19 vaccine. Tuesday's ruling relates to the London leg of Pfizer, BioNTech and CureVac's global legal battle, which also involves litigation in the ...

Although the pneumonia vaccine can’t prevent all cases, it can lower your chances of catching the disease. And if you’ve had the shot and you get pneumonia anyway, you will probably have a ...

As of 2024, there are three COVID-19 vaccines approved for use by the U.S. Food and Drug Administration (FDA): Pfizer-BioNTech (marketed under the brand name Comirnaty), an mRNA vaccine Moderna ...

This means adults have a choice in which COVID vaccine they receive: an mRNA vaccine by Moderna or Pfizer, or Novavax, a protein-based vaccine that targets the virus in a more "traditional" way.

The Public Health Agency of Canada (PHAC) says updated vaccines from Moderna and Pfizer-BioNTech are scheduled to arrive in provinces and territories by the end of next week. Pharmacies and public ...